PatientsVille.com Logo

MENORRHAGIA and Hydroxyzine

PatientsVille

MENORRHAGIA Symptoms and Causes

Menstruation, or period, is normal vaginal bleeding that occurs as part of a woman's monthly cycle. Every month, your body prepares for pregnancy. If no pregnancy occurs, the uterus, or womb, sheds its lining. The menstrual blood is partly blood and partly tissue from inside the uterus. It passes out of the body through the vagina.

Periods usually start between age 11 and 14 and continue until menopause at about age 51. They usually last from three to five days. Besides bleeding from the vagina, you may have

  • Abdominal or pelvic cramping pain
  • Lower back pain
  • Bloating and sore breasts
  • Food cravings
  • Mood swings and irritability
  • Headache and fatigue

Premenstrual syndrome, or PMS, is a group of symptoms that start before the period. It can include emotional and physical symptoms.

Consult your health care provider if you have big changes in your cycle. They may be signs of other problems that should be treated.

NIH: National Institute of Child Health and Human Development

Check out the latest treatments for MENORRHAGIA

MENORRHAGIA treatment research studies

Hydroxyzine clinical trials, surveys and public health registries


Find Drug Side Effect reports



Hydroxyzine Side Effects

Completed Suicide (135)
Poisoning (62)
Cardiac Arrest (62)
Respiratory Arrest (57)
Death (29)
Toxicity To Various Agents (21)
Overdose (20)
Cardio-respiratory Arrest (18)
Nausea (17)
Anxiety (17)
Dizziness (17)
Somnolence (16)
Headache (16)
Exposure Via Ingestion (15)
Pyrexia (15)
Suicide Attempt (14)
Fall (14)
Pain In Extremity (13)
Pain (13)
Dyspnoea (13)
Condition Aggravated (12)
Confusional State (12)
Tremor (12)
Pruritus (12)
Abdominal Pain (11)
Depression (11)
Vomiting (11)
Fatigue (11)
Convulsion (10)
Asthenia (10)
Diarrhoea (10)
Feeling Abnormal (10)
Tachycardia (10)
Oedema Peripheral (10)
Injection Site Pain (10)
Balance Disorder (9)
Insomnia (9)
Dermatitis Exfoliative (9)
Syncope (9)
Torsade De Pointes (9)
Paraesthesia (8)
Grand Mal Convulsion (8)
Hypotension (8)
Septic Shock (8)
Urticaria (8)
Malaise (7)
Injury (7)
Pleural Effusion (7)
Psoriasis (7)
Myocardial Infarction (7)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

MENORRHAGIA Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Comparing the Efficacy of Pregabalin and Hydroxyzine on the Anxiety Score
Condition: Feeling Anxious
Interventions: Drug: Hydroxyzine;   Drug: Pregabalin;   Drug: Lactose
Outcome Measures: Efficacy treatment;   Efficacy of pregabaldin
2 Recruiting Pain and Anxiety Management of Traumatic Emergency in a Pre-hospital Setting
Condition: Pain
Interventions: Drug: Atarax (Hydroxyzine);   Drug: Placebo
Outcome Measures: Percentage of patients with pain relief (with a NRS score of 3/10 or lower);   pain score comparisons;   pain and anxiety comparisons;   comparison of adverse events;   patient and investigator satisfaction with analgesia;   assessment of post traumatic anxiety, stress and other related disorders
3 Recruiting Does Preventive Analgesia Improve the Outcome of Demerol-Vistaril Procedural Sedations in Pediatric Dentistry
Condition: Pain
Interventions: Drug: oral placebo;   Drug: Oral Analgesics
Outcome Measures: Improved sedation effectiveness based on numerical value for effectiveness as noted in description;   Difference in heart rate as measured by numerical delta value
4 Recruiting Interaction Between Drug and Placebo Effect:Randomized Placebo Controlled Trials May Not be Accurate in Determining Drug Effect Size
Conditions: Placebo Effect;   Placebo Drug Interaction
Interventions: Drug: Hydroxizine;   Other: Placebo;   Drug: Hydroxyzine/placebo
Outcome Measures: Area-under-the-curve for drowsiness;   Area-under-the-curve for dryness of the mouth;   Mean percent of time of reporting drowsiness on a dichotomous scale.;   Mean percent of time of reporting dryness of mouth
5 Unknown  Enteral Versus Intravenous Sedation in Critically Ill High-risk ICU Patients
Conditions: Critical Illness;   Mechanical Ventilation Complication
Interventions: Procedure: Enteral Sedation (EN);   Procedure: Control group: Intravenous Sedation (IV)
Outcome Measures: Percent of efficacy, measured by observed RASS = desired RASS ± 1.;   Sedation protocol effectiveness: percentage of "protocol violation days" on the total of ICU days.;   Delirium and coma free days (respectively negative CAM-ICU and RASS > - 3 in all daily observations until 28° ICU day) (11);   Ventilation free days (12);   Nursing evaluation of sedation adequacy (communication skills, cooperation, environment tolerance) (13);   Overall ICU and hospital mortality, absolute mortality after 1 year from ICU discharge.;   Sedative drugs costs.;   Indirect inefficacy markers
6 Unknown  Neurocognitive Functioning Following The PROMETA® Treatment Protocol In Subjects With Alcohol Dependence
Condition: Alcohol Dependence
Intervention: Drug: Prometa Treatment Program
Outcome Measures: The primary outcome measure is neurocognitive functioning as assessed by a battery of standardized neurocognitive tests that assess, executive functioning, verbal memory, general intelligence, and attention.;   Secondary outcome measures include, alcohol craving, subject retention, percent of abstinent days, percent of heavy drinking days, time to first heavy drinking day, and blood chemistries including liver enzymes, reports of side effects.
7 Recruiting Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks
Condition: Major Depressive Disorder
Interventions: Drug: ketamine venlafaxine;   Drug: Venlafaxine
Outcome Measure: Depressive state